Pre-clinical efficacy and synergistic potential of the MDM2-p53 antagonists, Nutlin-3 and RG7388, as single agents and in combined treatment with cisplatin in ovarian cancer.
| Image |  |
|---|---|
| Description | scientific article published on 20 May 2016 |
| Author/s |
author: Richard Edmondson John Lunec |
| Publication date | June 1, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |